These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 28984154)
21. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis. Li C; Liu T; Yin L; Zuo D; Lin Y; Wang L Medicine (Baltimore); 2019 Mar; 98(9):e14659. PubMed ID: 30817589 [TBL] [Abstract][Full Text] [Related]
22. Role of CXCR4 and SDF1 as prognostic factors for survival and the association with clinicopathology in colorectal cancer: A systematic meta-analysis. Li YP; Pang J; Gao S; Bai PY; Wang WD; Kong P; Cui Y Tumour Biol; 2017 Jun; 39(6):1010428317706206. PubMed ID: 28621237 [TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of Notch1 expression in cervical cancer patients: a meta-analysis. Song L; Meng L; Peng J; Wang P; Qi S; Li W; Liu C; Li F Biomark Med; 2016; 10(1):63-72. PubMed ID: 26460922 [TBL] [Abstract][Full Text] [Related]
24. Upregulation of kallikrein‑related peptidase 5 is associated with the malignant behavior of colorectal cancer. Wu Y; Chen Y; Li Q; Gong Y; Liu X; Bi L; Hu C Mol Med Rep; 2016 Sep; 14(3):2164-70. PubMed ID: 27430713 [TBL] [Abstract][Full Text] [Related]
25. Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer. Xie Y; Song J; Zong Q; Wang A; Yang Y; Liu F; Meng X Hepatogastroenterology; 2015 May; 62(139):615-9. PubMed ID: 26897940 [TBL] [Abstract][Full Text] [Related]
26. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer. Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443 [TBL] [Abstract][Full Text] [Related]
27. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer. Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185 [TBL] [Abstract][Full Text] [Related]
28. High expression of C-X-C chemokine receptor 4 and Notch1 is predictive of lymphovascular invasion and poor prognosis in lung adenocarcinoma. Cong Z; Wu H; Guo Z; Qin T; Xu Y; Jing H; Wang Y; Shen Y Tumour Biol; 2017 Jun; 39(6):1010428317708698. PubMed ID: 28618922 [TBL] [Abstract][Full Text] [Related]
29. Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis. Yuan X; Wu H; Xu H; Han N; Chu Q; Yu S; Chen Y; Wu K Sci Rep; 2015 May; 5():10338. PubMed ID: 25996086 [TBL] [Abstract][Full Text] [Related]
30. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer. Li C; He X; Zhang L; Li L; Zhao W BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475 [TBL] [Abstract][Full Text] [Related]
31. Does overexpression of HER-2 correlate with clinicopathological characteristics and prognosis in colorectal cancer? Evidence from a meta-analysis. Wu SW; Ma CC; Li WH Diagn Pathol; 2015 Aug; 10():144. PubMed ID: 26276145 [TBL] [Abstract][Full Text] [Related]
32. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related]
33. c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer. Lee KS; Kwak Y; Nam KH; Kim DW; Kang SB; Choe G; Kim WH; Lee HS PLoS One; 2015; 10(10):e0139727. PubMed ID: 26426996 [TBL] [Abstract][Full Text] [Related]
34. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma. Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200 [TBL] [Abstract][Full Text] [Related]
35. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis. Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of Transcription Termination Factor 1 is Associated with a Poor Prognosis in Patients with Colorectal Cancer. Ueda M; Iguchi T; Nambara S; Saito T; Komatsu H; Sakimura S; Hirata H; Uchi R; Takano Y; Shinden Y; Eguchi H; Masuda T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1490-8. PubMed ID: 26036188 [TBL] [Abstract][Full Text] [Related]
37. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis. Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413 [TBL] [Abstract][Full Text] [Related]
38. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer. Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515 [TBL] [Abstract][Full Text] [Related]
39. Prognosis and Clinicopathology of CXCR4 in Colorectal Cancer Patients: a Meta-analysis. Li LN; Jiang KT; Tan P; Wang AH; Kong QY; Wang CY; Lu HR; Wang J Asian Pac J Cancer Prev; 2015; 16(9):4077-80. PubMed ID: 25987090 [TBL] [Abstract][Full Text] [Related]
40. Lgr5 expression is a valuable prognostic factor for colorectal cancer: evidence from a meta-analysis. Jiang Y; Li W; He X; Zhang H; Jiang F; Chen Z BMC Cancer; 2016 Jan; 16():12. PubMed ID: 26758198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]